Recap: Four Auto-Injectors on the Horizon


As recent events plainly indicate, consumers are painfully aware of the lack of competition and choice in the marketplace for epinephrine auto-injectors, the only drug indicated when life-threatening anaphylaxis strikes.

The problem was further exacerbated when Sanofi recalled their popular Auvi-Q device and announced an exit from the market in February. Since then, we have been reporting on alternatives making their way through the development and FDA approval process.

Click to visit sponsor

If you are interested in keeping abreast of the latest in auto-injector alternatives, keep your eye on our blog or subscribe to our Newsletter for periodic updates:

Subscribe to our weekly newsletter and never miss an important food allergy article! Unsubscribe at any time. We pledge never to share your address.

Here are articles we published in the past year on four noteworthy auto-injector designs currently at various stages in the pipeline with more to come:


Note of disclosure: Mylan is an advertiser with
Print or share this article
Print or share this article
Click to visit sponsor
Dave Bloom
Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of

Find Allergy-Friendly Products


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.